Humoral and cell-mediated immunity (CMI) against B. pertussis was assessed in a sample of adolescent, adult and senior subjects distributed in five different geographical areas in Italy. Most (99.1%) subjects had IgG anti-pertussis toxin (PT) antibodies exceeding the minimum detection level [> or = 2 ELISA units (EU)/ml]. There were no significant differences between the genders; 6.2% samples recorded titres > or = 100 EU/ml. CMI was positive [stimulation index (SI) > or = 5] against PT in 39.0% of all samples. This study suggests that B. pertussis continues to circulate in age groups that have been previously considered to be uninvolved in the circulation of this pathogen and that adolescent and adult pertussis boosters may be of value in these populations. Nevertheless, over the last 10 years, large increases in vaccination coverage rates have contributed to reduce the spread of the aetiological agent, especially in the immunized population.

Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy

GABUTTI, Giovanni
Co-primo
;
BERGAMINI, Mauro
Secondo
;
CAVALLARO, Alessandra;
2008

Abstract

Humoral and cell-mediated immunity (CMI) against B. pertussis was assessed in a sample of adolescent, adult and senior subjects distributed in five different geographical areas in Italy. Most (99.1%) subjects had IgG anti-pertussis toxin (PT) antibodies exceeding the minimum detection level [> or = 2 ELISA units (EU)/ml]. There were no significant differences between the genders; 6.2% samples recorded titres > or = 100 EU/ml. CMI was positive [stimulation index (SI) > or = 5] against PT in 39.0% of all samples. This study suggests that B. pertussis continues to circulate in age groups that have been previously considered to be uninvolved in the circulation of this pathogen and that adolescent and adult pertussis boosters may be of value in these populations. Nevertheless, over the last 10 years, large increases in vaccination coverage rates have contributed to reduce the spread of the aetiological agent, especially in the immunized population.
Gabutti, Giovanni; Bergamini, Mauro; P., Bonanni; M., Guido; D., Fenoglio; A., Giammanco; L., Sindoni; C., Zotti; V., Boddi; F., Bamfi; R., Severini; A., Bechini; S., Boccalini; P., Crovari; S., Ditommaso; M., Gentile; G., Lanci; P., Durando; L., Sticchi; A., Renzoni; P., Fuliano; G., Tripodi; Cavallaro, Alessandra; G., Pesavento; T., Silei Secchini; B., Innocenti; R., Squeri; V., La Fauci; S., Calimeri; D., Lo Giudice; A., De Donno; M., Quattrocchi; F., Sanapo; Pasanisi, G. C.; S., Taormina; C., Bonura; C., Cala; A., Ferrera
File in questo prodotto:
File Dimensione Formato  
Epidemiol Infect (2008) 136.pdf

accesso aperto

Descrizione: Full text editoriale
Tipologia: Full text (versione editoriale)
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 125.3 kB
Formato Adobe PDF
125.3 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/1652277
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 16
social impact